Outcome in patients with end‐stage renal disease following heart or heart–lung transplantation receiving peritoneal dialysis

Abstract

Increased risk of PD peritonitis and reduced PD survival is reported in this cohort of 17 heart and heart--lung recipients with ESRD. Nevertheless, for patients with severely impaired cardiac function, PD may still offer therapeutic advantage.